Top Skin Perfusion Pressure Testing Devices Companies

Skin Perfusion Pressure Testing Devices Market size was valued at USD 232.42 Million in 2024 and is poised to grow from USD 258.22 Million in 2025 to USD 599.38 Million by 2033, growing at a CAGR of 11.1% during the forecast period (2026–2033).

The global skin perfusion pressure testing devices market is marked by strong competition among prominent companies like Perimed AB, Moor Instruments, and Vasamed Incorporated. These key players continually invest in research and development to enhance their product offerings for assessing skin perfusion pressure, catering to the growing demand for accurate diagnostic tools in wound care and vascular disease management. Market expansion strategies, including mergers, acquisitions, and partnerships, are prevalent, as companies aim to broaden their geographical reach and product portfolios. Moreover, technological advancements and regulatory approvals play a crucial role in shaping the competitive landscape of this market, reflecting a commitment to improving healthcare outcomes. 'ADInstruments (Australia)', 'CorVascular Diagnostics, LLC (USA) ', 'Koven Technology (USA) ', 'Moor Instruments Limited (UK) ', 'Perimed AB (Sweden) ', 'Promed Group (Germany) ', 'Vasamed (USA) ', 'Viasonix (Israel) ', 'BIOPAC Systems Inc. (USA) ', 'ELCAT (Germany)'

The increasing incidence of peripheral vascular diseases, such as peripheral artery disease (PAD) and diabetes, is a major driver for the global skin perfusion pressure testing devices market. These conditions often lead to compromised blood circulation in extremities, necessitating non-invasive diagnostic tools like skin perfusion pressure testing devices for early detection and management.

Rising Incidence of Peripheral Artery Disease (PAD): The increasing prevalence of PAD, often linked to lifestyle factors such as diabetes and obesity, was driving the demand for skin perfusion pressure testing devices. These devices are essential for diagnosing and monitoring PAD, contributing to early intervention and better patient outcomes.

The global skin perfusion pressure testing devices market exhibits distinct regional patterns. North America, particularly the United States, dominates the market due to a robust healthcare infrastructure, high prevalence of chronic diseases like diabetes, and a strong emphasis on early disease detection.